Skip to content

Opening book details…

About this Medicine article

Phase 1 clinical trial of marizomib (MRZ, NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 (NCT00629473) final results by Harrison, S.J.; Catley, L.; Price, T.; Millward, M.J.; Padrik, P.; Underhill, C.R.; Cannell, P.K.; Burrows, F.J.; Reich, S.D.; Trikha, M.; Spencer, A. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Harrison, S.J.; Catley, L.; Price, T.; Millward, M.J.; Padrik, P.; Underhill, C.R.; Cannell, P.K.; Burrows, F.J.; Reich, S.D.; Trikha, M.; Spencer, A.
Publisher
Elsevier ; Cancer Media Group; Elsevier BV (ISSN 2152-2650)
Published
2015
Language
EN
Field
Medicine (Health Sciences)